Mentice AB (publ) (MNTC.ST)
- Previous Close
17.10 - Open
16.90 - Bid 16.05 x --
- Ask 16.35 x --
- Day's Range
15.80 - 17.05 - 52 Week Range
15.80 - 40.00 - Volume
159,322 - Avg. Volume
10,741 - Market Cap (intraday)
418.05M - Beta (5Y Monthly) 0.80
- PE Ratio (TTM)
-- - EPS (TTM)
-0.72 - Earnings Date Jul 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
41.12
Mentice AB (publ) develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations comprising the VIST virtual patient and Laerdal SimMan vascular medical simulator. It also provides flow model products, which include physiological flow systems, extensions and add-ons, silicone and 3D printed vessels, and flow system accessories; Ankyras, a clinical decision application; Mentice Live, a cloud-based learning center for medical technology industry and healthcare providers; Mentice Right Heart Cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; Vascular Twin, an anatomical replication for procedural and device adoption; and research and development services. Mentice AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.
www.mentice.comRecent News: MNTC.ST
View MorePerformance Overview: MNTC.ST
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MNTC.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MNTC.ST
View MoreValuation Measures
Market Cap
504.98M
Enterprise Value
460.53M
Trailing P/E
--
Forward P/E
65.79
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.74
Price/Book (mrq)
3.52
Enterprise Value/Revenue
1.59
Enterprise Value/EBITDA
25.17
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.31%
Return on Assets (ttm)
-2.13%
Return on Equity (ttm)
-12.17%
Revenue (ttm)
291.81M
Net Income Avi to Common (ttm)
-18.42M
Diluted EPS (ttm)
-0.72
Balance Sheet and Cash Flow
Total Cash (mrq)
53.59M
Total Debt/Equity (mrq)
6.36%
Levered Free Cash Flow (ttm)
6.42M